113 related articles for article (PubMed ID: 16794746)
1. Safety, immunogenicity and efficacy of influenza vaccine in children.
Cintra OA; Rey LC
J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S83-90. PubMed ID: 16794746
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccines in children.
Neuzil KM; Edwards KM
Semin Pediatr Infect Dis; 2002 Jul; 13(3):174-81. PubMed ID: 12199613
[TBL] [Abstract][Full Text] [Related]
3. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
El Sahly HM; Keitel WA
Expert Rev Vaccines; 2008 Aug; 7(6):713-9. PubMed ID: 18665769
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
5. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
Keitel WA
Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
[TBL] [Abstract][Full Text] [Related]
6. Rationale and approach to target children with asthma for annual influenza immunization.
Gaglani MJ
Semin Pediatr Infect Dis; 2002 Apr; 13(2):97-103. PubMed ID: 12122959
[TBL] [Abstract][Full Text] [Related]
7. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
[TBL] [Abstract][Full Text] [Related]
8. Trivalent intranasal influenza vaccine, live.
McCarthy MW; Kockler DR
Ann Pharmacother; 2004 Dec; 38(12):2086-93. PubMed ID: 15494383
[TBL] [Abstract][Full Text] [Related]
9. The use of inactivated influenza vaccine in children.
Wright PF
Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.
Frey S; Vesikari T; Szymczakiewicz-Multanowska A; Lattanzi M; Izu A; Groth N; Holmes S
Clin Infect Dis; 2010 Nov; 51(9):997-1004. PubMed ID: 20868284
[TBL] [Abstract][Full Text] [Related]
11. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
Esposito S; Principi N
Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials.
Pileggi C; Mascaro V; Bianco A; Nobile CG; Pavia M
Drugs Aging; 2015 Oct; 32(10):857-69. PubMed ID: 26442860
[TBL] [Abstract][Full Text] [Related]
13. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
Piedra PA
Semin Pediatr Infect Dis; 2002 Apr; 13(2):90-6. PubMed ID: 12122958
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination.
Zangwill KM; Belshe RB
Pediatr Infect Dis J; 2004 Mar; 23(3):189-97. PubMed ID: 15014289
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
17. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.
Beyer WE; Nauta JJ; Palache AM; Giezeman KM; Osterhaus AD
Vaccine; 2011 Aug; 29(34):5785-92. PubMed ID: 21624411
[TBL] [Abstract][Full Text] [Related]
19. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
